When two worlds collide: corporate and clinical governance
| dc.contributor.author | Gupte, A. | * |
| dc.contributor.author | McIntosh, Bryan | * |
| dc.contributor.author | Sheppy, B. | * |
| dc.date.accessioned | 2014-10-21T16:24:07Z | |
| dc.date.available | 2014-10-21T16:24:07Z | |
| dc.date.issued | 2012 | |
| dc.identifier.citation | Gupte A, McIntosh B and Sheppy B (2012) When two worlds collide: corporate and clinical governance. British Journal of Healthcare Management. 18(12): 619-620. | |
| dc.identifier.uri | http://hdl.handle.net/10454/6527 | |
| dc.description | No | |
| dc.description.abstract | Clinical and corporate governance have been an area of ongoing concerns in the NHS. Since the Bristol Royal Infirmary scandal of the 1990s and the events concerning Sir Jimmy Savile there has been a dilemma of its true nature and relationship. Clinical and corporate governance are closely related as the two of them share similar processes such as openness, performance review, striving for effective end results, and accountability in the use of resources and power within healthcare management. | |
| dc.language.iso | en | en |
| dc.subject | Clinical governance | |
| dc.subject | Corporate governance | |
| dc.subject | Effectiveness | |
| dc.subject | National Health Service (NHS) | |
| dc.subject | Community | |
| dc.subject | Quality of care | |
| dc.title | When two worlds collide: corporate and clinical governance | |
| dc.status.refereed | Yes | |
| dc.type | Article | |
| dc.type.version | No full-text in the repository | |
| dc.identifier.doi | https://doi.org/10.12968/bjhc.2012.18.12.619 | |
| dc.openaccess.status | closedAccess |